Bacteria-armed mosquitos approved for US release in fight against Zika, dengue and yellow fever

mosquito

The US Environmental Protection Agency (EPA) has approved the use of a common bacterium to kill wild mosquitoes that transmit viruses such as dengue, yellow fever and Zika…

[T]he agency told biotechnology start-up MosquitoMate that it could release the bacterium Wolbachia pipientis into the environment as a tool against the Asian tiger mosquito (Aedes albopictus). Lab-reared mosquitoes will deliver the bacterium to wild mosquito populations.

The decision — which the EPA has not formally announced — allows the company, which is based in Lexington, Kentucky, to release the bacteria-infected mosquitoes in 20 US states and Washington DC.

“It’s a non-chemical way of dealing with mosquitoes, so from that perspective, you’d think it would have a lot of appeal,” says David O’Brochta, an entomologist at the University of Maryland in Rockville.“I’m glad to see it pushed forward, as I think it could be potentially really important.”

…

The company will have to start small. Suppressing the mosquito population of an entire city is likely to require the weekly production of millions of these mosquitoes. To reach that level, [the] company must find a way to efficiently separate male mosquitoes from females. The company’s technicians now separate them both by hand and mechanically, [said Stephen Dobson, an entomologist at the University of Kentucky in Lexington and MosquitoMate’s founder.]

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: US government approves ‘killer’ mosquitoes to fight disease

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Sep-10-2026-10_36_07-AM
Viewpoint: Even lousy scientific articles can shield authors when they hype dubious health claims and products
ChatGPT-Image-Sep-23-2026-02_36_39-PM
Viewpoint: After firing the entire National Science Board, Trump reshapes funding initiatives. Here’s the good and the bad.
generated-1790707585414
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it
ChatGPT-Image-Sep-21-2026-03_15_09-PM
Viewpoint: Chipotle-inspired lesson: 10,000 sick customers suggest that processed foods can be safer than fresh ones
ChatGPT-Image-Sep-21-2026-11_54_00-AM
Viewpoint: Activist environmental NGOs are turning from public funding to activist billionaires to support their campaigns. It won’t end well.
ChatGPT-Image-Sep-22-2026-11_17_31-AM
The exploding controversy over AI’s built-in survival drive
Screenshot 2026-08-12 at 1.22
Activists vs. Scientists: Could “Butterfly Effect” fears derail gene-drive research targeting the flesh-eating screwworm?
Screenshot-2026-09-16-at-10.27.33-AM
Viewpoint: SCOTUS poised to address First Amendment tension between mandatory vaccines, children’s health and religious freedom 
sorghum farmers in kenya FARMERS TREND
Here are all the ways CRISPR gene editing is transforming Africa’s staple crops—and there’s a lot more innovation to come
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.